Ulcerative Colitis Clinical Trials
Ulcerative Colitis clinical trials study new biologics, small-molecule drugs, and treatment approaches for ulcerative Colitis and related immune or inflammatory conditions. Corterve gathers actively recruiting Ulcerative Colitis studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Ulcerative Colitis studies
- A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisNCT06598943PHASE2Eli Lilly and CompanyChandler, Arizona
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisNCT07012395PHASE2Spyre Therapeutics, Inc.Canoga Park, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345PHASE1National Cancer Institute (NCI)Birmingham, Alabama
- A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)NCT07463183PHASE2Merck Sharp & Dohme LLCAnaheim, California
- Zymfentra (Infliximab-dyyb) REal World Cohort STudyNCT07237516University of North Carolina, Chapel HillNew Haven, Connecticut
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)NCT06979336PHASE2Genentech, Inc.Lancaster, California
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisNCT07071519PHASE3AbbViePhoenix, Arizona
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisNCT06619990PHASE1, PHASE2Xencor, Inc.Scottsdale, Arizona
- An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative ColitisNCT07665723PHASE1Hoffmann-La RocheChula Vista, California
- Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel DiseaseNCT07456566NAUniversity of MichiganAnn Arbor, Michigan
- A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community SettingNCT06581328PHASE4TakedaBirmingham, Alabama
- Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced TherapiesNCT07427017PHASE2Northwestern UniversityChicago, Illinois
Ulcerative Colitis trials by state
Ulcerative Colitis trials by metro
Frequently asked questions
- How do I find recruiting Ulcerative Colitis clinical trials?
- Corterve aggregates actively recruiting Ulcerative Colitis studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Ulcerative Colitis clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Ulcerative Colitis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.